Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.400
+0.060 (4.48%)
At close: Jun 18, 2026, 4:00 PM EDT
1.390
-0.010 (-0.71%)
After-hours: Jun 18, 2026, 7:52 PM EDT

PACB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4355655392,6271,8534,521
Market Cap Growth
40.68%4.80%-79.49%41.76%-59.02%-9.36%
Enterprise Value
865.27987.57821.292,9292,0274,431
Last Close Price
1.401.871.839.818.1820.46
PS Ratio
2.723.533.5013.1014.4434.64
PB Ratio
183.73105.561.063.753.295.72
EV/Sales Ratio
5.416.175.3314.6015.8033.95
Debt / Equity Ratio
297.17131.241.311.321.671.20
Net Debt / Equity Ratio
180.6579.060.560.430.31-0.11
Net Debt / EBITDA Ratio
-3.59-2.47-0.65-0.96-0.590.45
Net Debt / FCF Ratio
-3.68-3.71-1.33-1.13-0.620.77
Asset Turnover
0.200.160.100.110.070.11
Inventory Turnover
1.982.021.862.722.093.67
Quick Ratio
4.674.326.307.033.0014.90
Current Ratio
5.655.157.487.813.2415.36
Return on Equity (ROE)
-3333.14%-213.45%-51.30%-48.53%-46.42%-32.18%
Return on Assets (ROA)
-17.12%-54.21%-31.59%-18.36%-16.28%-11.46%
Return on Invested Capital (ROIC)
-29.51%-86.49%-50.37%-29.48%-29.77%-27.58%
Return on Capital Employed (ROCE)
-18.66%-58.14%-33.34%-21.20%-17.87%-18.21%
Buyback Yield / Dilution
-7.43%-2.56%-9.96%-18.21%-2.50%-14.92%
Total Shareholder Return
-7.43%-2.56%-9.96%-18.21%-2.50%-14.92%
SEC Filings: 10-K · 10-Q